Flight Attendant Medical Research Institute
13
1
2
10
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 35/100
7.7%
1 terminated/withdrawn out of 13 trials
90.9%
+4.4% vs industry average
23%
3 trials in Phase 3/4
20%
2 of 10 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (13)
Secondhand Tobacco Smoke and Cardiovascular Disease
Role: collaborator
Secondhand Smoke Respiratory Health Study
Role: collaborator
Effects of Secondhand Smoke on Flight Attendant Health
Role: collaborator
The Effect of Chlorhexidine on the Oral and Lung Microbiota in Chronic Obstructive Pulmonary Disease
Role: collaborator
Effect of Losartan on Airway Mucociliary Dysfunction in Patients With COPD and Chronic Bronchitis
Role: collaborator
Meditative Movement for COPD Symptoms in Non-Smoking Flight Attendants
Role: collaborator
Nasal and Peripheral Blood Biomarkers of CRS Patients Before and After Surgical Intervention
Role: collaborator
Markers of Response to Intravesical Bladder Cancer Therapy
Role: collaborator
Reversal of Tobacco-Related Sinusitis
Role: collaborator
Prevention of Postpartum Smoking Relapse in Mothers of Infants in the Neonatal Intensive Care Unit (NICU)
Role: collaborator
Aortic Distensibility
Role: collaborator
Effectiveness of Pedialink CEASE Module
Role: collaborator
Secondhand Smoke Exposure Reduction Study
Role: collaborator
All 13 trials loaded